| Title : Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats - Mani_2022_Pharmaceuticals.(Basel)_15_ |
| Author(s) : Mani V , Rabbani SI , Shariq A , Amirthalingam P , Arfeen M |
| Ref : Pharmaceuticals (Basel) , 15 : , 2022 |
| Abstract : Mani_2022_Pharmaceuticals.(Basel)_15_ |
| ESTHER : Mani_2022_Pharmaceuticals.(Basel)_15_ |
| PubMedSearch : Mani_2022_Pharmaceuticals.(Basel)_15_ |
| PubMedID: 36559014 |
| Title : Levetiracetam Ameliorates Doxorubicin-Induced Chemobrain by Enhancing Cholinergic Transmission and Reducing Neuroinflammation Using an Experimental Rat Model and Molecular Docking Study - Mani_2022_Molecules_27_ |
| Author(s) : Mani V , Arfeen M , Rabbani SI , Shariq A , Amirthalingam P |
| Ref : Molecules , 27 : , 2022 |
| Abstract : Mani_2022_Molecules_27_ |
| ESTHER : Mani_2022_Molecules_27_ |
| PubMedSearch : Mani_2022_Molecules_27_ |
| PubMedID: 36364190 |